Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan in Recurrent Malignant Glioma
NCT00003616Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 1998
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in malignant glioma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00003616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003616.